The latest satisfaction survey results from Quilaban confirm the trust placed in the company by […]
Genetic disorders are among the leading causes of admission to neonatal and paediatric intensive care […]
We proudly celebrate 5 years of partnership between Quilaban and Illumina, a global leader in […]
Quilaban Recognised at the 2024 People Engagement Awards
For the Third Consecutive Year, Quilaban Is a Great Place to Work
Quilaban recognised again as a Happy Company
We have renewed our Scoring certifications
Quilaban Recognised by Great Place to Work® Portugal
5th place in the Excellence Index 2023
